A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland

  1. Sharon J. Peacock1,2,7,8
  1. 1University of Cambridge, Department of Medicine, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom;
  2. 2The Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom;
  3. 3British Society for Antimicrobial Chemotherapy, Birmingham B1 3NJ, United Kingdom;
  4. 4North Bristol NHS Trust, Southmead Hospital, Bristol, BS10 5NB, United Kingdom;
  5. 5Culture Collections, Public Health England, Porton Down, Salisbury SP4 0JG, United Kingdom;
  6. 6Public Health England, Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom;
  7. 7Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom;
  8. 8London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom
  1. Corresponding author: ker37{at}medschl.cam.ac.uk

Abstract

Vancomycin-resistant Enterococcus faecium (VREfm) is an important cause of healthcare-associated infections worldwide. We undertook whole-genome sequencing (WGS) of 495 E. faecium bloodstream isolates from 2001–2011 in the United Kingdom and Ireland (UK&I) and 11 E. faecium isolates from a reference collection. Comparison between WGS and multilocus sequence typing (MLST) identified major discrepancies for 17% of isolates, with multiple instances of the same sequence type (ST) being located in genetically distant positions in the WGS tree. This confirms that WGS is superior to MLST for evolutionary analyses and is more accurate than current typing methods used during outbreak investigations. E. faecium has been categorized as belonging to three clades (Clades A1, hospital-associated; A2, animal-associated; and B, community-associated). Phylogenetic analysis of our isolates replicated the distinction between Clade A (97% of isolates) and Clade B but did not support the subdivision of Clade A into Clade A1 and A2. Phylogeographic analyses revealed that Clade A had been introduced multiple times into each hospital referral network or country, indicating frequent movement of E. faecium between regions that rarely share hospital patients. Numerous genetic clusters contained highly related vanA-positive and -negative E. faecium, which implies that control of vancomycin-resistant enterococci (VRE) in hospitals also requires consideration of vancomycin-susceptible E. faecium. Our findings reveal the evolution and dissemination of hospital-associated E. faecium in the UK&I and provide evidence for WGS as an instrument for infection control.

Footnotes

  • [Supplemental material is available for this article.]

  • Article published online before print. Article, supplemental material, and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.204024.116.

  • Freely available online through the Genome Research Open Access option.

  • Received January 4, 2016.
  • Accepted August 15, 2016.

This article, published in Genome Research, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.

| Table of Contents
OPEN ACCESS ARTICLE

Preprint Server